Honan will lead the company in identifying and executing acquisitions that complement Emmes’ existing strong federal government client base, expand its biopharma portfolio, enhance its technology offerings, and broaden its global reach
The unit will have installed manufacturing capacity of over 15 million vials annually that includes lyophilized vials, all in the anti-cancer segment
The company is one of the most profitable companies manufacturing speciality chemicals in India
Allam was serving recently as the CEO at Public Investment Fund
According to IQVIA sales data for the 12-month period ending October 2022, the Cardene Capsules, 20 mg and 30 mg market achieved annual sales of approximately US $10.9 million
36.4% of patients with diabetic neuropathic pain in 2021 were completely treatment refractory and would benefit from new treatment options.
Positive opinions based on significant survival benefit
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
The current ruling will assure the safety of the use of Ranitidine for Indian patients
Subscribe To Our Newsletter & Stay Updated
